• Impact of a Tele-rehabilitation Program on People With Multiple Sclerosis

  NCT07178834

  Active, not recruitingInterventionalNot ApplicableUpdated Sep 17, 2025
• Physical Telerehabilitation in Multiple Sclerosis

  NCT03230903

  CompletedInterventionalNot ApplicableUpdated Feb 18, 2021
• Telerehabilitation in Progressive Multiple Sclerosis

  NCT06485115

  Unknown statusInterventionalNot ApplicableUpdated Jul 3, 2024
• Hybrid Rehabilitation Approach Through Group Exercise and Telerehabilitation in Patients With Multiple Sclerosis

  NCT05469568

  Active, not recruitingInterventionalNot ApplicableUpdated Sep 29, 2025
• Effectiveness of Telerehabilitation Interventions in Multiple Sclerosis

  NCT05571826

  Unknown statusObservationalUpdated Oct 7, 2022
• Physical Telerehabilitation in Veterans With Multiple Sclerosis

  NCT02346734

  CompletedInterventionalNot ApplicableUpdated May 5, 2026

ClinicalTrials.gov ID

NCT07310914

Lead Sponsor

Danish Multiple Sclerosis HospitalsOTHER

Overall Status

Not yet recruiting

Study Type

Interventional

Phase

Phase 2

Enrollment

94Estimated

Last Update Posted

Dec 30, 2025Actual

Start Date

Feb 1, 2026Estimated

Primary Completion Date

Dec 31, 2026Estimated

Completion Date

Jul 1, 2027Estimated

Official Title

Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis

Brief Summary

The overall purpose of the present study is to investigate the effect of an advanced telerehablitation system (TRS) in persons with multiple sclerosis on mobility. The advanced telerhabilitation system is based on AI components, and delivers instant feedback to the partcipants. If the project is successful, it can help optimize exercise for those persons with multiple sclerosis who are either not able or willing to travel to a clinical setting for exericse.

• Multiple Sclerosis

• Telerehabilitation
• Paper-based exercise

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Definite diagnosis of MS according to the McDonald criteria (both relapse-remitting and progressive)
• Expanded Disability Status Scale (EDSS) score of 2.5 to 6.5 or Patient Determined Disability Score (PDDS) of 2 to 6, indicating preservation of at least some ambulatory function, that is, the ability to walk 20 meters or more, independently, with or without the use of an assistive device
• Willingness to travel to the local study site for the evaluation sessions,
• Internet platform availability

Exclusion Criteria:

• comorbidities hindering participation in the study.
• Individuals who have had a documented relapse and/or corticoid treatment during the past three months will be excluded,
• Individuals with severe cognitive deficits who cannot follow simple instructions and/or consent.

Primary Purpose

Treatment

Allocation

Randomized

Interventional Model

Parallel Assignment

Masking

None (Open Label)

Lead Sponsor

Danish Multiple Sclerosis HospitalsOTHER

Collaborators

MS IrelandUNKNOWN

Tel Aviv UniversityOTHER

University of CagliariOTHER

University of LimerickOTHER

larshv@sclerosehospital.dk+4593508717

susanc@ms-society.ie+353 86 036 4109

alonkalron@gmail.com+972 52 243 6839

massimiliano.pau@unica.it+39 338 782 5240